Peter S. Kim
Director · Entrada Therapeutics, Inc.
- 2025
- Jun 12, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter S. Kim files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M in TRDA purchases and sales in the last 12 months
- MPM BioVentures 2014, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $3.60M in TRDA purchases and sales in the last 12 months
- 5AM Ventures V, L.P. - $3.00M in TRDA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $1.61M in TRDA purchases and sales in the last 12 months
- Kory James Wentworth - $434K in TRDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter S. Kim?
Peter S. Kim is a corporate insider, tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Peter S. Kim last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 3 filings going back to 2025.
Has Peter S. Kim been buying or selling stock?
Recorded transactions: 2 open-market purchases ($732K) and 0 open-market sales across all tracked filings.
